Getting Tested

How testing works, who qualifies, and the step-by-step process

How BRCA Testing Works

Testing requires a blood or saliva sample sent to a lab. Results take 2–4 weeks and fall into one of three categories:

✅

Positive

A harmful mutation was found. Your care team will build a risk management plan.

❎

Negative

No known harmful mutation found. Enhanced screening may still be recommended if family history is strong.

❓

VUS

Variant of uncertain significance. A change was found, but its impact is not yet known. Monitoring continues.

Who Qualifies? The USPSTF Criteria

The U.S. Preventive Services Task Force (USPSTF) sets the criteria that trigger zero-cost ACA coverage. It's a two-step process:

Step 1: Do You Meet at Least One of These?

🏥

Personal History

You have had breast, ovarian, tubal, or peritoneal cancer (including if cancer-free after treatment).

👪

Family History

Relatives on either side of the family with breast, ovarian, tubal, or peritoneal cancer.

🌍

Ancestry

Ashkenazi Jewish or other ancestry associated with elevated BRCA mutation rates.

Meeting any one of these qualifies you for a formal risk assessment using a validated screening tool. This is a Grade B recommendation, meaning the ACA requires non-grandfathered plans to cover both the counseling and testing at $0.

Step 2: What the Screening Tools Look For

Your clinician uses a validated tool (not just an informal conversation) to score your risk. These tools evaluate:

📅

Age at Diagnosis

Breast cancer before age 50

⚖️

Bilateral Cancer

Cancer in both breasts

👨

Male Breast Cancer

Any male relative with breast cancer

📊

Multiple Cases

Several family members affected

🔬

Two Cancer Types

One person with two BRCA-related cancers

🌐

Ancestry

Ashkenazi Jewish or other high-risk heritage

View all USPSTF-validated screening tools
ToolNotes
Ontario Family History Assessment ToolWidely validated across multiple studies
Manchester Scoring SystemPoints-based, accounting for cancer type and age
Referral Screening Tool (B-RST)Among the simplest; available at breastcancergenescreen.org
Pedigree Assessment ToolAssigns points per affected family member; quick
7-Question Family History ToolBrief questionnaire format
Tyrer-Cuzick (IBIS)International Breast Cancer Intervention Study
BRCAPRO (brief versions)Statistical model estimating mutation probability

Note: General breast cancer risk tools (like the Gail model) are not appropriate here. Those estimate overall risk, not the likelihood of a specific genetic mutation.

The Testing Process

Here's how it works from start to finish:

1

Assess Your Risk

Review personal and family cancer history. Look for early-onset breast cancer, ovarian cancer, pancreatic cancer, male breast cancer, or high-risk ancestry.

2

Talk to a Provider

Discuss your history with your primary care provider, OB/GYN, or oncologist. They can refer you to a genetic counselor. Or call FORCE at 866-288-RISK, ext. 704 for a free referral.

3

Genetic Counseling

A counselor reviews your risk in depth, explains testing, discusses what results could mean, and helps navigate insurance. Some insurers require this step before covering the test.

4

Verify Insurance Coverage

Call your insurer before testing. If you meet USPSTF criteria with a non-grandfathered ACA plan, your cost should be $0. See the Insurance & Aid page if coverage is denied or you're uninsured.

5

Get Tested

A simple blood draw or saliva sample. Results arrive in 2–4 weeks.

6

Review Results

Go over results with your genetic counselor, whether positive, negative, or VUS. A positive result leads to a personalized risk management plan.

7

Family Cascade Testing

If a mutation is found, first-degree relatives should be offered testing. Testing for a known mutation is simpler and less expensive than the initial test.

Gaps in the Current Criteria

👨

Men Excluded

USPSTF covers women only. Many insurers still cover men under standard medical necessity, but it's not guaranteed.

❔

Unknown Family History

No guidance for adopted individuals, small families, or those estranged from biological relatives.

🧬

BRCA Only

Other cancer genes (ATM, CHEK2, PALB2, Lynch) are not covered under this recommendation.

📝

Under Revision

The USPSTF began updating the 2019 criteria in January 2025. Changes may broaden eligibility.

Continue reading

Insurance & Financial Aid →